Cargando…
Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells
In this study we attempted to determine the molecular mechanisms underlying the two mature products of pre-miR-140 (3p and 5p) in malignant properties of lung cancer cells. The differential expression of the two forms of miR-140 in both NSCLC tissues and cell lines was determined by quantitative rea...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284864/ https://www.ncbi.nlm.nih.gov/pubmed/30559931 http://dx.doi.org/10.18632/oncotarget.26356 |
_version_ | 1783379383192387584 |
---|---|
author | Flamini, Valentina Dudley, Ed Jiang, Wen G. Cui, Yuxin |
author_facet | Flamini, Valentina Dudley, Ed Jiang, Wen G. Cui, Yuxin |
author_sort | Flamini, Valentina |
collection | PubMed |
description | In this study we attempted to determine the molecular mechanisms underlying the two mature products of pre-miR-140 (3p and 5p) in malignant properties of lung cancer cells. The differential expression of the two forms of miR-140 in both NSCLC tissues and cell lines was determined by quantitative real-time PCR (qRT-PCR). The effects of the miR-140 mimics on the malignant properties of lung cancer cells were evaluated using invasion assay, adhesion assay, tubule formation assay and metabolite profiling. Biotin-miRNA pulldown and transcriptome profiling by RNA-seq were utilized to distinguish their mRNA targets of the miR-140 strands. Their downstream signalling pathways were unveiled using a high-throughput antibody array. Although both strands of the miR-140 are downregulated in the NSCLC, miR-140-3p is more predominant compared to miR-140-5p in lung cancer cell lines. Both miR-140 mimics suppress the invasion of lung cancer cells and the inhibitory effect of the miR-140 on adhesion is cell-dependent. Tumor conditioned media from A549 cells after treatment with miR-140-3p mimic reduce the tubule formation ability of the endothelial cells. Metabolite profiling indicates the alteration of glycine in both lung cancer cells following treatment with miR-140 mimics. The data from the RNA-sequencing and antibody array indicate that two miR-140 strands present different targeting and signalling profiles despite the existence of mutual targets such as IGF1R and FOS. In conclusion, two forms of miR-140 both suppress the malignant properties of lung cancer cells but through distinct and multiple mechanisms. |
format | Online Article Text |
id | pubmed-6284864 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-62848642018-12-17 Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells Flamini, Valentina Dudley, Ed Jiang, Wen G. Cui, Yuxin Oncotarget Research Paper In this study we attempted to determine the molecular mechanisms underlying the two mature products of pre-miR-140 (3p and 5p) in malignant properties of lung cancer cells. The differential expression of the two forms of miR-140 in both NSCLC tissues and cell lines was determined by quantitative real-time PCR (qRT-PCR). The effects of the miR-140 mimics on the malignant properties of lung cancer cells were evaluated using invasion assay, adhesion assay, tubule formation assay and metabolite profiling. Biotin-miRNA pulldown and transcriptome profiling by RNA-seq were utilized to distinguish their mRNA targets of the miR-140 strands. Their downstream signalling pathways were unveiled using a high-throughput antibody array. Although both strands of the miR-140 are downregulated in the NSCLC, miR-140-3p is more predominant compared to miR-140-5p in lung cancer cell lines. Both miR-140 mimics suppress the invasion of lung cancer cells and the inhibitory effect of the miR-140 on adhesion is cell-dependent. Tumor conditioned media from A549 cells after treatment with miR-140-3p mimic reduce the tubule formation ability of the endothelial cells. Metabolite profiling indicates the alteration of glycine in both lung cancer cells following treatment with miR-140 mimics. The data from the RNA-sequencing and antibody array indicate that two miR-140 strands present different targeting and signalling profiles despite the existence of mutual targets such as IGF1R and FOS. In conclusion, two forms of miR-140 both suppress the malignant properties of lung cancer cells but through distinct and multiple mechanisms. Impact Journals LLC 2018-11-23 /pmc/articles/PMC6284864/ /pubmed/30559931 http://dx.doi.org/10.18632/oncotarget.26356 Text en Copyright: © 2018 Flamini et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Flamini, Valentina Dudley, Ed Jiang, Wen G. Cui, Yuxin Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells |
title | Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells |
title_full | Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells |
title_fullStr | Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells |
title_full_unstemmed | Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells |
title_short | Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells |
title_sort | distinct mechanisms by which two forms of mir-140 suppress the malignant properties of lung cancer cells |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284864/ https://www.ncbi.nlm.nih.gov/pubmed/30559931 http://dx.doi.org/10.18632/oncotarget.26356 |
work_keys_str_mv | AT flaminivalentina distinctmechanismsbywhichtwoformsofmir140suppressthemalignantpropertiesoflungcancercells AT dudleyed distinctmechanismsbywhichtwoformsofmir140suppressthemalignantpropertiesoflungcancercells AT jiangweng distinctmechanismsbywhichtwoformsofmir140suppressthemalignantpropertiesoflungcancercells AT cuiyuxin distinctmechanismsbywhichtwoformsofmir140suppressthemalignantpropertiesoflungcancercells |